Given comparable data to a study using markers CD5/CXCR4 [8], CD5/CD19 coexpression might represent a combination of markers capable of reflecting biological differences between CLL clones, an assumption that needs to be verified in future studies. The gene discussed is CD5; the disease is B-cell chronic lymphocytic leukemia.